Get Premium Data for Cyber Monday: Up to 55% Off InvestingProCLAIM SALE

GSK plc (GSK)

London
Currency in GBP
1,341.50
-13.50(-1.00%)
Closed
GSK Scorecard
Full Analysis
High shareholder yield
High dividend Yield
Fair Value
Day's Range
1,329.881,356.00
52 wk Range
1,282.501,823.50
Key Statistics
Edit
Bid/Ask
1,303.00 / 1,398.00
Prev. Close
1,355
Open
1,345.5
Day's Range
1,329.88-1,356
52 wk Range
1,282.5-1,823.5
Volume
6.61M
Average Volume (3m)
8.69M
1-Year Change
-5.88%
Fair Value
unlockUnlock
Fair Value Upside
unlockUnlock
GSK Scorecardpro icon
Company’s Health
pro lockUnlock
Fair Value
pro lockUnlock Price
Fair Pricepro lock
Upsidepro lock
Price Target
1,817.43
Upside
+35.48%
Members' Sentiments
Bearish
Bullish
ProTips
3 analysts have revised their earnings downwards for the upcoming period
Show more

GSK plc Company Profile

GSK plc, together with its subsidiaries, engages in the research, development, and manufacture of vaccines, and specialty and general medicines to prevent and treat disease in the United Kingdom, the United States, and internationally. It operates through two segments, Commercial Operations and Total R&D. The company offers shingles, meningitis, respiratory syncytial virus, flu, polio, influenza, and pandemic vaccines. It also provides medicines for HIV, oncology, respiratory/immunology, and other specialty medicine products, as well as inhaled medicines for asthma and chronic obstructive pulmonary disease, and antibiotics for infections. It has a collaboration agreement with CureVac to develop mRNA-based influenza vaccines, and with Wave Life Sciences and Elsie Biotechnologies, Inc for oligonucleotide platform development; and multi-target strategic alliance with GSK to develop breakthrough treatments for people afflicted with Parkinson’s disease; as well as collaboration with Flagship Pioneering to discover novel medicines and vaccines. The company was formerly known as GlaxoSmithKline plc and changed its name to GSK plc in May 2022. GSK plc was founded in 1715 and is headquartered in Brentford, the United Kingdom.dom.

Employees
70212

Compare GSK to Peers and Sector

Metrics to compare
GSK
Peers
Sector
Relationship
P/E Ratio
22.0x15.9x−0.7x
PEG Ratio
−0.370.150.00
Price/Book
3.9x1.9x2.6x
Price / LTM Sales
1.8x2.5x3.2x
Upside (Analyst Target)
20.3%20.0%45.9%
Fair Value Upside
Unlock11.8%7.6%Unlock

Analysts' Recommendations

7 Buy
9 Hold
3 Sell
Ratings:
18 analysts
Overall Consensus
Buy

Analysts 12-Month Price Target:

Average 1,817.43

(+35.48% Upside)

Dividends

Payout Ratio
Payout ratio (TTM)
Earnings retained
EPS 0.617
Dividend Yield
4.50%
Industry Median 2.52%
Annualized payout
61
Paid unevenly
5-Years Growth
-9.41%
Growth Streak

People Also Watch

10,618.0
AZN
+1.32%
4,966.0
RIO
-0.82%
19.50
BAYGN
+1.25%
679.20
ASML
-0.63%
53.66
LLOY
+1.25%

FAQ

What Is the GSK plc (GSK) Stock Price Today?

The GSK plc stock price today is 1,341.50

What Stock Exchange Does GSK plc Trade On?

GSK plc is listed and trades on the London stock exchange.

What Is the Stock Symbol for GSK plc?

The stock symbol for GSK plc is "GSK."

Does GSK plc Pay Dividends? What’s The Current Dividend Yield?

The GSK plc dividend yield is 4.50%.

What Is the GSK plc Market Cap?

As of today, GSK plc market cap is 54.67B.

What is GSK plc Earnings Per Share?

The GSK plc EPS is 0.617.

What Is the Next GSK plc Earnings Date?

GSK plc will release its next earnings report on Feb 04, 2025.

From a Technical Analysis Perspective, Is GSK a Buy or Sell?

Based on moving averages and other technical indicators, the daily buy/sell signal is Strong Sell.
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2024 - Fusion Media Limited. All Rights Reserved.